Treatment of Lung Cancer: 2020 ASCO Highlights

Register Now

Overview: This one hour live session will synthesize lung cancer research presented at the May 29-31, 2020 virtual meeting of the American Society of Clinical Oncology (ASCO). It will address physicians’ need to keep abreast of current research and future trends to inform clinical practice.

Dr. Chandra Belani will moderate the program and lead the discussion and question and answer session following presentations by Taofeek Owonikoko, MD and Melissa Johnson, MD. Dr. Owonikoko will review Small Cell Lung Cancer (SCLC), locally advanced non-small cell lung cancer (NSCLC) and Mesothelioma. Dr. Johnson will review metastatic NSCLC.

At the end of the webinar, learners will be able to:
– identify recent data impacting the overall management of lung cancer patients
– recognize new and evolving developments in standard treatment paradigms
– discuss the status of ongoing and future trials

Target Audience: This activity is designed to meet the educational needs of researchers and healthcare professionals who diagnose and treat patients with lung cancer including medical oncologists, thoracic surgeons, radiation oncologists, radiologists, pathologists, advanced practice nurses and physician assistants.

Participants
Dr. Chandra Belani, IASLC CSO, joins Drs. Taofeek Owonikoko and Melissa Johnson to discuss the most exciting news for the lung cancer community that came out of ASCO 2020.